Acadia Healthcare Company Inc (NASDAQ:ACHC) shares fell 5.3% on Wednesday . The stock traded as low as $39.97 and last traded at $40.00. 1,090,661 shares changed hands during trading, an increase of 7% from the average session volume of 1,015,409 shares. The stock had previously closed at $42.23.
Several research firms have weighed in on ACHC. ValuEngine lowered Acadia Healthcare from a “sell” rating to a “strong sell” rating in a research report on Thursday. BidaskClub raised Acadia Healthcare from a “hold” rating to a “buy” rating in a research note on Thursday. Zacks Investment Research raised Acadia Healthcare from a “hold” rating to a “buy” rating and set a $48.00 price objective for the company in a research note on Tuesday, July 24th. Credit Suisse Group increased their price objective on Acadia Healthcare from $40.00 to $44.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 31st. Finally, Jefferies Financial Group increased their price objective on Acadia Healthcare from $44.00 to $47.00 and gave the stock a “buy” rating in a research note on Tuesday, July 31st. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have issued a buy rating to the company’s stock. Acadia Healthcare presently has an average rating of “Buy” and an average target price of $44.36.
The company has a market capitalization of $3.53 billion, a price-to-earnings ratio of 17.32, a price-to-earnings-growth ratio of 1.43 and a beta of 0.62. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.24 and a current ratio of 1.24.
Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Monday, July 30th. The company reported $0.70 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.70. The firm had revenue of $765.70 million during the quarter, compared to analysts’ expectations of $767.93 million. Acadia Healthcare had a net margin of 7.52% and a return on equity of 7.93%. Acadia Healthcare’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.66 EPS. research analysts expect that Acadia Healthcare Company Inc will post 2.52 earnings per share for the current year.
In related news, Director Reeve B. Waud sold 8,135 shares of the firm’s stock in a transaction that occurred on Thursday, July 26th. The shares were sold at an average price of $45.00, for a total value of $366,075.00. Following the sale, the director now directly owns 14,213 shares of the company’s stock, valued at $639,585. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 11.10% of the stock is owned by corporate insiders.
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. TD Asset Management Inc. grew its stake in shares of Acadia Healthcare by 5.1% in the 2nd quarter. TD Asset Management Inc. now owns 263,323 shares of the company’s stock valued at $10,773,000 after buying an additional 12,800 shares in the last quarter. Eagle Boston Investment Management Inc. raised its holdings in shares of Acadia Healthcare by 9.7% during the second quarter. Eagle Boston Investment Management Inc. now owns 276,483 shares of the company’s stock worth $11,310,000 after purchasing an additional 24,436 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Acadia Healthcare by 27.8% during the second quarter. Dimensional Fund Advisors LP now owns 5,153,977 shares of the company’s stock worth $210,849,000 after purchasing an additional 1,122,452 shares during the last quarter. State Board of Administration of Florida Retirement System raised its holdings in shares of Acadia Healthcare by 6.2% during the first quarter. State Board of Administration of Florida Retirement System now owns 72,984 shares of the company’s stock worth $2,860,000 after purchasing an additional 4,261 shares during the last quarter. Finally, BB&T Corp raised its holdings in shares of Acadia Healthcare by 14.5% during the second quarter. BB&T Corp now owns 44,620 shares of the company’s stock worth $1,826,000 after purchasing an additional 5,667 shares during the last quarter.
About Acadia Healthcare (NASDAQ:ACHC)
Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.
Further Reading: Calculate Your Return on Investment (ROI)
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.